EPITOPE: A double-blind, placebo-controlled, randomized phase III trial to assess the safety and efficacy of Viaskin® Peanut in peanut-allergic young children 1-3 years of age

Project: Research project

Project Details

StatusActive
Effective start/end date5/17/188/31/50

Funding

  • DBV Technologies